An Evidence about The Role of Basal Insulin Glargine 300 U/mL Post-GLP-1 Therapy
Dr. Ritzzel discusses the efficacy of Glar300 in individuals inadequately controlled on GLP-1 RA. This engaging talk provides a deep understanding of how Glar300 can enhance diabetes management and improve patient outcomes. Don’t miss out on this opportunity to enhance your understanding and improve patient outcomes.
![](/.imaging/webp/sanofi-templates/w1080-16-9/dam/campus-sanofi-ae/science/an-evidence/video-poster.jpg/jcr:content/video-poster.jpg)
Related articles
MAT-BH-2400349/v1/MAY2024